Detalhe da pesquisa
1.
A systematic review on the appropriate discounting rates for the economic evaluation of gene therapies: whether a specific approach is justified to tackle the challenges?
Int J Technol Assess Health Care
; 40(1): e23, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38725378
2.
Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands.
Cardiovasc Diabetol
; 22(1): 328, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017448
3.
Cost-effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK.
Eur J Haematol
; 110(3): 262-270, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398467
4.
Oncology from an HTA and Health Economic Perspective.
Recent Results Cancer Res
; 213: 25-38, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30543005
5.
Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies.
BMC Health Serv Res
; 19(1): 22, 2019 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30626376
6.
Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease.
J Mark Access Health Policy
; 12(2): 35-57, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38660414
7.
Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients with Haemophilia B Without Inhibitors.
Adv Ther
; 41(6): 2307-2323, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652439
8.
The cost-effectiveness of pegcetacoplan in complement treatment-naïve adults with paroxysmal nocturnal hemoglobinuria in the USA.
J Comp Eff Res
; 12(10): e230055, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37655691
9.
The impact of amortization of gene therapies funding on the results and conclusions of CEMs and BIMs.
J Mark Access Health Policy
; 11(1): 2232648, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440980
10.
Gene Therapy Evidence Generation and Economic Analysis: Pragmatic Considerations to Facilitate Fit-for-Purpose Health Technology Assessment.
Front Public Health
; 10: 773629, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35223725
11.
Challenges in the market access of regenerative medicines, and implications for manufacturers and decision-makers: a systematic review.
Regen Med
; 17(3): 119-139, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042424
12.
Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe.
J Med Econ
; 25(1): 1068-1075, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35993970
13.
The cost-effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting.
J Comp Eff Res
; 11(13): 969-985, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796199
14.
Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes.
Am J Manag Care
; 28(6 Suppl): S104-S111, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997774
15.
Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies.
Expert Rev Pharmacoecon Outcomes Res
; 21(6): 1145-1158, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407704
16.
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models.
J Mark Access Health Policy
; 9(1): 2002006, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34790341
17.
Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis.
Adv Ther
; 38(6): 3113-3128, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934279
18.
FINE-CKD model to evaluate economic value of finerenone in patients with chronic kidney disease and type 2 diabetes.
Am J Manag Care
; 27(20 Suppl): S375-S382, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878755